Upload
abena
View
47
Download
0
Embed Size (px)
DESCRIPTION
Veterinary products and aquatic animals. Peter Smith Chair OIE ad hoc Group on the responsible use of antimicrobials in aquatic animals. Veterinary products . Vaccines Disinfectants Anti-parasitics Antibiotics. Antibiotics. FAO Definition - PowerPoint PPT Presentation
Citation preview
Veterinary products and aquatic animals
Peter Smith
Chair OIE ad hoc Group on the responsible use of antimicrobials in aquatic animals
Veterinary products
Vaccines
Disinfectants
Anti-parasitics
Antibiotics
Antibiotics
FAO Definition‘a drug of natural or synthetic origin, with the capacity to inhibit the growth of or to kill microorganisms. Antibiotics that are sufficiently non-toxic to the host are used as chemotherapeutic agents in the treatment of infectious diseases of man, animals and plants.’
Reasons for antibiotic use in aquaculture
Prevention (good husbandry and correct use of vaccines) is the best way of reducing disease risks
but
When bacterial infections occurs in farmed animals antibiotics are the only therapy that will
reduce loses
Reasons why antibiotic use must beprudent
Antibiotics are powerful chemicals - biologically active at low concentrations
Aquacultural use involves the deliberate introduction of these chemicals into the food chain and the environment
Use of antibiotics lead to the emergence of resistant bacteria and resistance compromises their value as therapeutic agents
Presence of residues may affect consumers of aquaculture products
Public perception of a “drug-based” industry and results in reduced market acceptability of aquaculture products
Resistance to antibiotics
Resistance and aquatic animal health
There is clear evidence that resistance to antibiotics has emerged when these agents are used in aquaculture
The more we use (and misuse) these agents the smaller is the chance that antibiotics will be effective therapeutically
We run the risk of entering the ‘pre-antibiotic’ era
Resistance to antibiotics
Resistance and human health
Resistance to antibiotics is global
There is a risk that antibiotic resistance selected by aquacultural use will compromise therapy of human infections
Pressure from human medicine (WHO) may reduce availability of antibiotics to aquaculture
Presence of unacceptable residues
Presence of any residues of banned antibiotics
or
Presence of levels of other antibiotics above maximum allowed limit
Will have major trade implications
Overall strategy to ensure prudent use
Regulation
Monitoring
Education
A new draft chapter of theOIE Aquatic Animal Code
is being prepared
It will primarily address issues of the regulation and the monitoring/surveillance of
the use of antibiotics in aquaculture
This talk is an introduction to some of these issues
Current global status
There is huge variety in the extent and the style of regulation and monitoring/surveillance of antibiotic use in aquaculture
Some authorities have very sophisticated procedures but the majority, including many responsible for large production volumes, have not
Current global status
Regulation
Central to regulation is the licensing of antibiotic containing products
by the granting of
Marketing Authorizations
Current global status
Regulation
Very few antibiotics are licensed for aquaculture
Many countries have licensed no antibioticsSome have only licensed a few (2-4)
Some large industries (shrimp) have no licensed antibiotics
Current global status
Monitoring
We have little (quality) information on the consequence (target bacteria resistance) of
antibiotic use in aquaculture
We have no accurate estimates of the amount of antibiotics used in aquaculture
The way forward
The way forward - Regulation
Aims
To ensure that antibiotics used in aquaculture are safe to the animals treated and to the consumers
To ensure that antibiotics are used in a way that is likely to be efficacious (cost/effective)
To ensure all stakeholders are informed of their duties and responsibilities
The way forward - Regulation
Regulations based on Marketing Authorization
Only products for which MA have been granted should be used in aquaculture
MA will facilitatecorrect product labeling
and definition ofthe responsibilities and duties of all stakeholders
The way forward - Regulation
Marketing authorizations
Safety (treated animals, users and to consumers)
and
Efficacy
The way forward - Regulation
Safety to consumers
Maximum residue level (MRL)independent of species and rearing conditions - internationally set
Withdrawal timetime after therapy when residue is below MRLdependent on species and rearing conditions – locally set
The way forward - Regulation
Efficacy
Establish thata specified dose regimen delivered
using a specified antibiotic containing product will control loses resulting from a specified bacterial infection
of a specified speciesunder specified environmental conditions
The way forward - Regulation
Problems with basing regulation on MA
MA are expensive and time-consuming to produce
(who pays?)
MA are specific but disease conditions encountered in aquaculture are diverse
The way forward - Regulation
Problems with basing regulation on MA
There will always be a need for extra/off label
use of antibiotics in aquaculture
The way forward – Monitoring resistance
Information on resistance in target bacteria is essential:
to ensure individual therapies are rational and prudent
to understand emerging patterns of resistance nationally, regionally and globally
to inform risk assessment
The way forward – Monitoring resistance
We are in the process ofstandardizing and harmonizing laboratory methods
for measuring susceptibility in aquatic bacteria
We possess no quality information on resistance in bacteria that infect fish
Embarrasing fact
After 50 years of research we have no clear procedures for establishing if a bacterium isolated from an aquatic animal will be
resistant or sensitive to an antibiotic therapy
The way forward – Monitoring resistance
Determining resistance involves 2 stages
Development of appropriate standardized laboratory protocols
Developing interpretive criteria that allow meaning (sensitive/resistant)
to be given to the results of these laboratory tests
The way forward – Monitoring resistance
Test protocols
There is general agreement that the test protocols outlined in the CLSI documents
M42-A and M49 -A should be adopted
Current status of CLSI resistance methods
Test protocol Interpretive criteriaAeromonas salmonicida + +
Aeromonas spp +Edwardsiella spp +
Flavobacterium spp +Photobacterium spp. +Streptococcus spp. ?
Photobacterium spp +Vibrio spp +
Piscirickettsia salmonis
Vibrio salmonicida ?Tenacibaculum maritimum ?
Francisella spp ?
We know how to do the tests
but
We don’t know what the results mean
Current status of CLSI methods
Interpretive criteria
There is an urgent need for progress
Progress can be made on a species by species basis
Not all species are relevant to all industries or all regulatory authorities
The work required to set criteria for one species is not expensive or time-consuming
The way forward – Monitoring use
Data on how much antibiotics are being used is essential:
to understand emerging patterns of resistance
to inform and monitor strategic planning
to perform risk analysis
The way forward – Monitoring use
Use data requirementsEssential
Absolute amount (kg active drug) usedAnimals treated (species, number, weight)
Rationale for use (diagnosis, therapy/prophylaxis)
AdditionalMode of administration, type of husbandry system, environmental conditions etc
Risk analysis
What are the risks that use of antibiotics in aquaculture will select for resistances that will have a negative impact on human therapies?
A very difficult question to answer
Risk analysis
Risks associated with aquacultural use much less than those associated with use in
land-based agriculture
Risk primarily associated with selection of transferable resistance factors in
environmental bacteria
Risks associated with resistant bacteria in aquaculture products less important
Antimicrobial Resistance (AMR) Risk Analysis in Aquaculture
Discussion on the applicability of risk analysis principles for AMR in aquaculture
Thursday, 30 June 2011 8:30 amSpeakers Room/Salon Republicco
To receive a copy of a white paper describing the topic drafted by the OIE ad hoc Group on antimicrobial resistance in aquatic animals send a message to
Prudent use of antibiotics
Farmers buy and use antibiotics because they think/hope that it will increase their profits
Much use by farmers is inappropriate and imprudent
The greatest gain in prudent use and economic efficiency will be achieved by providing farmers with quality advice
Prudent use of antibiotics - education
Education programmes to train farmers and their on-farm advisors in the
correct use of antibioticsand
the provision of adequate and local diagnostic and antibiotic susceptibility testing
services
Will greatly reduce imprudent use